Merck (MRK) Tops Q3 EPS by 40c, Beats on Revenue; Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $144.67 -2.49%
Financial Fact:
Restructuring costs: 545.6M
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Restructuring costs: 545.6M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q3 EPS of $2.49, $0.40 better than the analyst estimate of $2.09. Revenue for the quarter came in at $18.1 billion versus the consensus estimate of $17.28 billion.
GUIDANCE:
Merck sees FY2026 EPS of $2.77-$2.82, versus the consensus of $2.65. Merck sees FY2026 revenue of $66.8-67.3 billion, versus the consensus of $67.04 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Flux Power Holdings, Inc. (FLUX) Misses Q1 EPS by 3c
- Claros Mortgage Trust, Inc. (CMTG) Tops Q3 EPS by 31c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
